Narita, Japan

Yoshihiko Kanamaru


Average Co-Inventor Count = 7.8

ph-index = 3

Forward Citations = 18(Granted Patents)


Location History:

  • Tomisato-machi, JP (1999)
  • Narita, JP (1991 - 2002)

Company Filing History:


Years Active: 1991-2002

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Yoshihiko Kanamaru

Introduction

Yoshihiko Kanamaru is a notable inventor based in Narita, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of 5 patents. His work focuses on developing innovative compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents are the following: 4-hydroxy-4-phenylpiperidine derivatives and pharmaceuticals containing the same, as well as substituted benzylurea derivatives and medicine containing the same. The substituted benzylurea derivatives are represented by a specific general formula, wherein various groups can be independently selected. These derivatives or their salts are known to strongly inhibit ACAT in macrophages, making them useful as prophylactic and therapeutic agents for arteriosclerosis.

Career Highlights

Throughout his career, Yoshihiko Kanamaru has worked with prominent companies such as Ss Pharmaceutical Co., Ltd. and Ssp Co. Ltd. His innovative work in the pharmaceutical industry has led to advancements in drug development and therapeutic solutions.

Collaborations

Yoshihiko has collaborated with notable individuals in his field, including Teruo Komoto and Susumu Sato. These collaborations have contributed to the success of his research and the development of his patented inventions.

Conclusion

Yoshihiko Kanamaru's contributions to the pharmaceutical industry through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to impact the field positively, paving the way for future advancements in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…